Discover
DAWN
Day One Biopharmaceuticals, Inc.
21.53
2 x 15.47
2 x 27.50
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
21.50 -0.03 (0.14%)
| Ytd | 131.01% | |
| 1y | 172.53% |
21.49
day range
21.53
5.63
52 week range
21.53
| Open | 21.49 | Prev Close | 21.53 | Low | 21.49 | High | 21.53 | Mkt Cap | 2.22B |
| Vol | 2.56M | Avg Vol | 4.00M | EPS | -1.04 | P/E | N/A | Forward P/E | -177.57 |
| Beta | -1.75 | Short Ratio | 2.79 | Inst. Own | 83.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 18.63 | 200-d Avg | 10.96 | 1yr Est | 21.50 |
| Income Statement | |||
| Total Revenue | 53.72M | ||
| Revenues (USD) | 53.72M | ||
| Cost of Revenue | 6.08M | ||
| Gross Profit | 47.64M | ||
| Operating Expenses | 75.10M | ||
| Research and Development Expense | 40.95M | ||
| Selling, General and Administrative Expense | 34.15M | ||
| Operating Income | -27.46M | ||
| Income Tax Expense | -1.98M | ||
| Net Income | -21.28M | ||
| Net Income Common Stock | -21.28M | ||
| Net Income Common Stock (USD) | -21.28M | ||
| Consolidated Income | -21.28M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -23.25M | ||
| Earning Before Interest & Taxes (USD) | -23.25M | ||
| Weighted Average Shares | 103.65M | ||
| Weighted Average Shares Diluted | 103.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 197.08M | ||
| Cash and Equivalents (USD) | 197.08M | ||
| Investments | 244.04M | ||
| Investments Current | 244.04M | ||
| Trade and Non-Trade Receivables | 26.74M | ||
| Current Assets | 485.10M | ||
| Property, Plant & Equipment Net | 4.48M | ||
| Total Assets | 507.83M | ||
| Debt Current | 174.00K | ||
| Total Debt | 2.79M | ||
| Current Liabilities | 60.52M | ||
| Debt Non-Current | 2.62M | ||
| Total Liabilities | 66.67M | ||
| Accumulated Retained Earnings (Deficit) | -661.40M | ||
| Accumulated Other Comprehensive Income | 65.00K | ||
| Shareholders Equity | 441.16M | ||
| Shareholders Equity (USD) | 441.16M | ||
| Assets Non-Current | 22.73M | ||
| Total Debt (USD) | 2.79M | ||
| Deferred Revenue | 5.04M | ||
| Goodwill and Intangible Assets | 18.02M | ||
| Inventory | 6.33M | ||
| Liabilities Non-Current | 6.14M | ||
| Trade and Non-Trade Payables | 3.73M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 994.00K | ||
| Net Cash Flow from Financing | 471.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 153.80M | ||
| Issuance (Purchase) of Equity Shares | 345.00K | ||
| Net Cash Flow from Investing | 167.48M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 167.48M | ||
| Net Cash Flow from Operations | -14.15M | ||
| Share Based Compensation | 11.07M | ||